USNA
USANA Health Sciences Inc
USANA Health Sciences Inc historical holders
total: 1
Jensen Investment Management USANA Health Sciences Inc transactions over time
- Total transactions:
- 5
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Held since:
- 2016 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2016 Q4
Eric H. Schoenstein has been an institutional investor in USANA Health Sciences Inc (USNA) since 2014 Q2. According to 2026 Q1 report, Eric H. Schoenstein doesn't hold any shares. The fund/company first acquired USNA in 2014 Q2, initially purchasing 13,560 shares. Eric H. Schoenstein later completely sold out the position and reinvested in USNA again in 2016 Q3. Since the initial investment, Jensen Investment Management has made 4 more transactions in this position.
When did Eric H. Schoenstein exit their USNA position?
Eric H. Schoenstein no longer holds USANA Health Sciences Inc (USNA). They sold off their entire position in 2016 Q4, closing out an investment that began in 2014 Q2.
When did Eric H. Schoenstein first invest in USNA?
Eric H. Schoenstein first invested in USANA Health Sciences Inc (USNA) in 2014 Q2 at the reported quarter-end price of $39.09 per share, acquiring 13,560 shares in their initial purchase.
What is Eric H. Schoenstein's average cost basis for USNA?
Based on historical transaction data, Eric H. Schoenstein's estimated cost basis for USANA Health Sciences Inc (USNA) is approximately $69.21 per share. This represents their average reported price* across all buy transactions.
Has Eric H. Schoenstein reinvested in USNA after selling?
Yes, Eric H. Schoenstein has shown renewed interest in USANA Health Sciences Inc (USNA). After completely selling their position, they reinitiated an investment in 2016 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $69.21
- Weighted AVG sell price:
- $69.21
USNA transactions history by Jensen Investment Management
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q4
|
0.00%
|
$69.21
|
-100% (-7,080)
|
|||
|
2016 Q3
|
0.01%
|
$69.21
|
new
|
|||
|
2014 Q4
|
0.00%
|
$36.85
|
-100% (-13,840)
|
|||
|
2014 Q3
|
0.01%
|
$36.85
|
+2.06% (+280)
|
|||
|
2014 Q2
|
0.01%
|
$39.09
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.